Analysis of the resistance profile of real-world alectinib first-line therapy in patients with ALK rearrangement-positive advanced non-small cell lung cancer using organoid technology in one case of lung cancer - Xie, Yingbo; Zhang, Yuxin; Wu, Yongqing; Xie, Xiaohong; Lin, Xinqing; Tang, Qing; Zhou, Chengzhi; Xie, Zhanhong (Journal of Thoracic Disease; Vol 16, No 6 (June 30, 2024): Journal of Thoracic Disease, 2024)